From: Jeffrey Epstein <jeevacation@gmail.com>
To: Boris Nikolic
Subject: Re: FW: Materials at request of David Rubenstein
Date: Tue, 04 Feb 2014 13:03:47 +0000
just copy caryllyes. ten times better
On Tue, Feb 4, 2014 at 2:51 AM, Boris Nikolic > wrote:
PPM from the Carlyle
Check out 10 years plus 31
Board of Advisors structure etc very similar.
2.5% fee.
Co-investments, parallel funds etc.
B
From: Ryan Schwarz [mailto
Sent: Wednesday, April 27, 20118:17 AM
To: Boris Nikolic
Subject: RE: Materials at request of David Rubenstein
Boris,
Good to see you again in Washington a couple weeks back. I hope you've been well.
The placement memo for our new global healthcare fund is now pretty much finalized, and David and I wanted to share
it with you. I've attached it to this email. We'd very much like to discuss the fund with you further, and to that end I'd
be happy to meet with you in Seattle (or elsewhere) if that would be desirable and would facilitate a discussion.
EFTA00871237
Best regards,
Ryan
Ryan M. Schwarz
Managing Director
THE CARLYLE GROUP
From: Boris Nikolic [mailto:
Sent: Friday, March 11, 2011 2:21 AM
To: Ryan Schwarz
Subject: RE: Materials at request of David Rubenstein
Hi Ryan,
Great meeting you earlier in day.
I made my flight but barely. There was no traffic. It was a luck.
Your fund is very interesting and there are a number of synergies. I look forward to discussing it in more details with
you as you are developing it.
Please keep me posted.
If you have any plans of visiting Seattle, please let me know
All the best
Boris
EFTA00871238
From: Ryan Schwarz rmailto: J
Sent: Wednesday, March 09, 2011 11:28 AM
To: Boris Nikolic
Subject: Materials at request of David Rubenstein
Boris,
David asked me to send you the two attached documents before our meeting tomorrow. One is a high-level concept
piece on the global healthcare venture fund idea that we prepared to help David introduce the concept to folks around
Carlyle. It provides an overview of the market opportunity as we see it, though of course with much less detail around
investment strategy and emphases than will be included in the eventual fund placement memo and presentation. The
other is a confidential summary of an investment opportunity that we are pursuing involving Xigris, the sole approved,
on-market drug for severe sepsis.
I look forward to seeing you in the morning.
Ryan
Ryan M. Schwarz
Managing Director
THE CARLYLE GROUP
********************************* ***********************************************
< CONFIDENTIALITY NOTICE >
The information contained in this transmission is intended only for the person or entity to which it is addressed
and may contain confidential, trade secret and/or privileged material. If you are not the intended recipient of
this information, do not review, retransmit, disclose, disseminate, use, or take any action in reliance upon, this
information. If you received this transmission in error, please contact the sender and destroy all printed copies
and delete the material from all computers.
********************************************************************************
< CONFIDENTIALITY NOTICE >
The information contained in this transmission is intended only for the person or entity to which it is addressed
and may contain confidential, trade secret and/or privileged material. If you are not the intended recipient of
EFTA00871239
this information, do not review, retransmit, disclose, disseminate, use, or take any action in reliance upon, this
information. If you received this transmission in error, please contact the sender and destroy all printed copies
and delete the material from all computers.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation@gmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00871240